320 filings
Page 2 of 16
424B3
8g0vvn4z8 12cy4y2wrx
21 Sep 23
Prospectus supplement
10:27am
RW
3g1voelmy muw
21 Sep 23
Registration withdrawal request
10:25am
UPLOAD
2ekn vrc3
19 Sep 23
Letter from SEC
12:00am
CORRESP
tuv3qz8td
19 Sep 23
Correspondence with SEC
12:00am
D
t9mo66afnjah 8nr4
13 Sep 23
$13.55 mm in equity / options / securities to be acquired, sold $13.55 mm, 1 investor
4:45pm
8-K
3dy78nk
6 Sep 23
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
8:30am
8-K
v3fypdl1
1 Sep 23
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
4:30pm
8-K
7w3ffi
30 Aug 23
NanoVibronix Cites Positive Results from Independent Testing of UroShield
8:30am
8-K
yndhjfn
29 Aug 23
Regulation FD Disclosure
4:05pm
8-K
0eh4k1 mmqxqejlu2r
28 Aug 23
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:30am
8-K
1tixyews4sz 4z9o57i
23 Aug 23
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
4:45pm
EFFECT
iuswgmh34nd 16trrsyh
14 Aug 23
Notice of effectiveness
12:15am
CORRESP
mzzl 2w2l3
9 Aug 23
Correspondence with SEC
12:00am
UPLOAD
jlxnujlhsnyzn0ajbs
9 Aug 23
Letter from SEC
12:00am
8-K
vdsp8 51b071pun15r17
20 Jul 23
Other Events
4:45pm